APA Alıntı

Coghlan, J. G., Channick, R., Chin, K., Di Scala, L., Galiè, N., Ghofrani, H., . . . Gaine, S. (2018). Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study. Am J Cardiovasc Drugs.

Chicago Stili Alıntı

Coghlan, J. Gerry, et al. "Targeting the Prostacyclin Pathway With Selexipag in Patients With Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights From the Randomized Controlled GRIPHON Study." Am J Cardiovasc Drugs 2018.

MLA Alıntı

Coghlan, J. Gerry, et al. "Targeting the Prostacyclin Pathway With Selexipag in Patients With Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights From the Randomized Controlled GRIPHON Study." Am J Cardiovasc Drugs 2018.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..